About

About

Immunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases.

About Us

Immunic Therapeuctics

Immunic is developing three small molecule products: lead development program, vidofludimus calcium (IMU-838), a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH and exhibits a host-based antiviral effect, is currently being developed as a treatment option for multiple sclerosis, and primary sclerosing cholangitis. IMU-935, a selective inverse agonist of the transcription factor RORγ/RORγt, is targeted for development in psoriasis, castration-resistant prostate cancer and Guillain-Barré syndrome. IMU-856, which targets the restoration of the intestinal barrier function, is targeted for development in diseases involving bowel barrier dysfunction.

Immunic, Inc. is headquartered in New York City. Its subsidiary, Immunic AG, is based in Gräfelfing near Munich, Germany, where the company’s research and development activities are conducted. Additional subsidiaries are located in Halle (Saale), Germany, and Melbourne, Australia.

Immunic AG was founded in 2016 with headquarters in Planegg-Martinsried, Germany. Since April 2019, the company has been operating under the name Immunic, Inc. with its registered office in the United States and has been trading on the Nasdaq Stock Market under the ticker symbol ”IMUX.” The listing followed a reverse takeover transaction with US-based Vital Therapies, Inc.

Management

Chief Executive Officer,
President and Director
Chief Scientific Officer
Chief Medical Officer
Chief Business Officer
Chief Financial Officer
General Counsel
Executive Chairman

Board of Directors

Executive Chairman
Chief Executive Officer,
President and Director

Scientific-Medical Advisory Board

Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Stanford University School of Medicine

Questions?
Get in touch.

Immunic Inc, ( Nasdaq: IMUX ) Stock Quote:

Loading data...

Currency in USD. Quote data delayed at least 15 minutes.